SCHEMBL12300577

SCHEMBL12300577

BCC(=O)c1ccc(B)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 7/20 0.38
▸ PTPN1 P18031 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ CES1 P23141 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALPI P09923 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333038 0.93 SMN1; SMN2 (0.44) GSK3BPTPN1RAB9AKDM4EMAPT
SCHEMBL12819956 0.82 SMN1; SMN2 (0.50) GSK3BPTPN1RAB9AKDM4EMAPT
SCHEMBL13460757 0.80 KDM4E (0.41) GSK3BPTPN1NPC1RAB9AKDM4E
SCHEMBL12153522 0.80 NPC1 (0.60) PTPN1NPC1RAB9AKDM4ETDP1
SCHEMBL12521014 0.79 PTPN1 (0.46) PTPN1NPC1RAB9AKDM4ETDP1
SCHEMBL13655368 0.78 TPMT (0.52) GSK3BPTPN1NPC1RAB9A
SCHEMBL9611581 0.78 HDAC3 (0.38) GSK3BPTPN1NPC1RAB9AKDM4E
SCHEMBL17613140 0.78 SMN1; SMN2 (0.57) GSK3BNPC1RAB9AKDM4ETDP1
SCHEMBL13191468 0.78 MAPT (0.45) NPC1RAB9AKDM4ETDP1KMT2A
SCHEMBL8751033 0.78 GSK3B (0.64) GSK3BNPC1RAB9AKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013021344-A1 IMIDAZOLE DERIVATIVES AS ANTIVIRAL AGENTS LUPIN LIMITED (IN) 2013-02-14 — — WO disclosed
WO-2012166716-A2 SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS ACHILLION PHARMACEUTICALS, INC. (US) 2012-12-06 — — WO disclosed
WO-2012125598-A1 BENZODIOXANE INHIBITORS OF LEUKOTRIENE PRODUCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-09-20 — — WO disclosed
WO-2012048421-A1 HEPATITIS C INHIBITOR COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-04-19 — — WO disclosed
WO-2011112429-A1 FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES SCHERING CORPORATION (US) 2011-09-15 — — WO disclosed
WO-2009102318-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 — — WO disclosed
Send feedback